Global PFO Amplatzer Market Size, Share, Growth Analysis, By Type(Amplatzer PFO Occluder), By Application(Hospitals, Clinics) - Industry Forecast 2022-2028

The Global PFO Amplatzer Market is valued at USD 154.71 Million in 2021, and it is anticipated to attain a value of USD 337.76 Million by 2028, at a CAGR of 11.8% over the forecast period (2022-2028).

Global PFO Amplatzer refers to the consumption and production of cocoa and chocolate products in the Asia Pacific region. The Asia Pacific region includes countries such as China, India, Japan, South Korea, Australia, and New Zealand, among others. Top-down and bottom-up approaches were used to estimate and validate the size of Global PFO Amplatzer and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The Global PFO Amplatzer Market is segmented based on type, application, and region. Based on Type it is categorized into Amplatzer PFO Occluder. By Application, the market study is segmented into hospitals, clinics and others end users. Based on the region it is categorized into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

The prevalence of ischemic stroke is a major determinant of the Amplatzer market. Ischemic stroke is the second leading cause of death globally, with over 795,000 cases reported annually in the US alone, of which approximately 87% are ischemic strokes. Lifestyle-related risk factors such as smoking, alcohol consumption, drug abuse, and a sedentary lifestyle are contributing to an increase in the incidence of stroke.

Restraint

The market for Amplatzer may face obstacles due to product recalls or discontinuation. Various companies have halted the production of their Amplatzer products. For instance, W. L. Gore and Associates, Inc terminated their GORE HELEX Septal Occluder in 2013 after being accused of patent infringement. Similarly, in 2013, St. Jude Medical conducted a Class I labeled item review of the Amplatzer PFO Occluder by the FDA.

Trend

The Asia Pacific region is expected to experience the fastest growth in the market for PFO closure devices due to the increasing awareness among the population regarding patent foramen ovale (PFO). On the other hand, North America currently dominates the market with the largest market share, owing to the high prevalence of ischemic stroke in the region. Factors such as changes in food habits and lifestyle among consumers, as well as increased disposable income, are contributing to a rise in the incidence of cardiovascular diseases and heart attacks.